Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1
result was found. Results that relate to
Unresectable
Efficacy and safety of tislelizumab combined with sorafenib in the treatment for unresectable hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(8):1136-1342.
912 times
193 times
JIANG Jinghua
HU Yiting
Tirilizumab
Sorafenib
Unresectable
Hepatocellular carcinoma
Objective response rate
Disease control rate
Progression-free survival
Overall survival
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University